A study published Tuesday in The New England Journal of Medicine showed that children between the ages of six and 12 who took ...

An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.

BioMarin’s new business strategy leaves investors with questions; Lykos CEO steps down; Terns releases compelling data on ...

The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for ...

A recent study estimated that Wegovy’s label expansion beyond obesity could push Medicare spending to $145 billion annually, ...

Jill Drury, Pharm.D., MBA, is a medical director for AbbVie. She has decades of diverse healthcare experience and is known ...

Tuesday’s round brings Bain Capital Life Sciences’ fundraising total to around $6.7 billion since its founding in 2016. Many ...

No patients have received Casgevy, CRISPR Therapeutics and Vertex Pharmeceuticals’ recently approved sickle cell gene therapy ...

Without revealing specific details, GSK announced that it is terminating the development of its investigational herpes ...

On the heels of Terns’ positive Phase I results that analysts compared with Lilly’s and Pfizer’s weight loss pills in ...

Plus, learn about what to expect in initial interviews and how to time your post-Ph.D. job search for maximum success.

Healthcare players are pointing fingers amid regulatory crackdowns on pharmacy benefit managers, but proposed reforms ...